Quick Answer
MapLight Therapeutics, Inc. reported Cash And Cash Equivalents At Carrying Value of $46.73 million for the year ending 2025.
- MapLight Therapeutics, Inc. showed an increase of +22.2% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from MapLight Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $46.73 million | Fiscal year 2024: $38.25 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: